Sangamo Therapeutics (SGMOQ) Minority Interest (2018 - 2021)
Sangamo Therapeutics (SGMOQ) posted quarterly Minority Interest of -$938000.0 for Q1 2021, down 856.45% year-over-year from $124000.0 in Q1 2020, and down 8.06% quarter-over-quarter from -$868000.0 in Q4 2020.
Sangamo Therapeutics (SGMOQ) Minority Interest (2018 - 2021) Analysis & Trends
Sangamo Therapeutics' Minority Interest history runs 4 years deep, the most recent figure standing at -$938000.0 for Q1 2021.
- In Q1 2021, Minority Interest fell 856.45% year-over-year to -$938000.0; the TTM figure through Mar 2021 stood at -$938000.0 (down 856.45% YoY), while the FY2020 annual figure was -$868000.0, down 569.19% from the prior year.
- Minority Interest for Q1 2021 stood at -$938000.0, down from -$868000.0 in the prior quarter.
- The five-year high for Minority Interest was $739000.0 in Q4 2018, with the low at -$938000.0 in Q1 2021.
- The 4-year median for Minority Interest is $154500.0 (2019), against an average of $0.0.
- The sharpest annual moves came in 2019 and 2021: Minority Interest plunged 74.97% in 2019, then tumbled 856.45% in 2021.
- Sangamo Therapeutics' Minority Interest stood at $739000.0 in 2018, then slumped by 74.97% to $185000.0 in 2019, then sank by 569.19% to -$868000.0 in 2020, then decreased by 8.06% to -$938000.0 in 2021.
- Business Quant data shows SGMOQ's Minority Interest at -$938000.0 in Q1 2021, -$868000.0 in Q4 2020, and -$530000.0 in Q3 2020.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | -938,000.00 |
| Dec 31, 2020 | -868,000.00 |
| Sep 30, 2020 | -530,000.00 |
| Jun 30, 2020 | -251,000.00 |
| Mar 31, 2020 | 124,000.00 |
| Dec 31, 2019 | 185,000.00 |
| Sep 30, 2019 | 239,000.00 |
| Jun 30, 2019 | 614,000.00 |
| Mar 31, 2019 | 686,000.00 |
| Dec 31, 2018 | 739,000.00 |